Breast cancer (early) - hormonal treatments

Hormonal therapies for the adjuvant treatment of early breast cancer

Status:	History
Expected date of issue:	November 2006
Wave:	8
Process:	MTA
Topic area: Cancer

Project team | Schedule | Stakeholders | Project history | Key documents

 

NICE project team

Executive Lead:	Andrea Sutcliffe
Technical Lead:	Zoe Charles
Communications manager:	Sarita Tamber
Project manager:	Alana Miller
Assessment group:	School of Health & Related Research, University of Sheffield

Top

 

Provisional schedule

Consultation on draft scope by stakeholders:	March 2005
Information meeting with consultees:	07 July 2005
Closing date for invited submissions / evidence submission:	20 September 2005
Final scope published:	May 2005
1st appraisal committee meeting:	27 April 2006
2nd appraisal committee meeting	21 June 2006

Top

 

Consultees and Commentators

Consultees Commentators (no right of appeal) Manufacturers / Sponsors AstraZeneca (anastrozole) Novartis Pharma Ltd (letrozole) Pfizer Ltd (exemestane) Patient / Carer Groups Breakthrough Breast Cancer Breast Cancer Care Breast Cancer Campaign CancerBACUP Professional Groups Association of Surgeons of Great Britain & Ireland British Association of Surgical Oncology British Oncology Pharmacy Association (BOPA) Cancer Research UK Royal College of Nursing Royal College of Pathologists Royal College of Physicians? Medical Oncology Joint Special Committee Royal Pharmaceutical Society Society for Endrocrinology Others Department of Health Welsh Assembly Government General British National Formulary Medicines and Healthcare products Regulatory Agency (MHRA) NHS Quality Improvement Scotland Comparator Manufacturers AstraZeneca (tamoxifen) Assessment Team National Coordinating Centre for Health Technology Assessment School of Health & Related Research Sheffield Associated Guideline Groups National Collaborating Centre for Cancer Associated Public Health Groups None Research Groups Institute of Cancer Research National Cancer Research Institute

Top

 

Project history

Date Summary 14 July 2003 Project suspended - see press release and update statements below for more information 25 January 2005 Project Manager updated. 4 March 2005 Provisional schedule updated. 17 March 2005 Provisional schedule updated. 6 May 2005 Draft scope and provisional matrix added. 24 May 2005 Final scope, matrix of consultees and commentators and responses to the draft scope and draft matrix published. 27 May 2005 Provisional schedule updated. 15 August 2005 Final protocol and amended final scope published. 13 February 2006 Consultees and Commentators updated. 30 May 2006 Project team updated. 9 June 2006 Stakeholders updated.

Top

 

Key documents

Breast cancer (early) - hormonal treatments - Final appraisal determination 11 August 2006 Breast cancer (early)- hormonal treatments (appraisal consultation document) 23 May 2006 Overview - Breast cancer (early) - hormonal treatments 23 May 2006 Assessment report, addendum and revised tables - Breast cancer (early) - hormonal treatments 23 May 2006 Consultee and commentator comments on the assessment report 23 May 2006 Non-manufacturer submissions 23 May 2006 Manufacturer submissions (executive summary only) 23 May 2006 Expert written personal statements 23 May 2006 Final protocol 15 August 2005 Final scope 24 May 2005 Response to consultee and commentator comments on the draft scope 24 May 2005 Response to consultee and commentator comments on the provisional matrix of consultees and commentators 24 May 2005 Archive: Breast cancer (early) - hormonal treatments - Draft scope 06 May 2005 Archive - Breast cancer (early) - hormonal treatments: Provisional matrix of consultees and commentators 06 May 2005 2003/030 Update on appraisal of hormonal treatments for the treatment of early breast cancer, compared with tamoxifen 14 July 2003 Update: Technology appraisal of hormonal treatments for the adjuvant treatment of oestrogen-receptor positive breast cancer, compared with tamoxifen 14 July 2003 2003/009 NICE asked to develop guidance on treating eczema, support programmes for parents dealing with conduct disorder in children, use of statins for heart disease, and when hysterectomy is appropriate 31 March 2003

This page was last updated:   09 June 2006